RT @OncBrothers@twitter.com

1. #SABCS22 updates w/ @ErikaHamilton9@twitter.com from @SarahCannonDocs@twitter.com on Her 2 #breastcancer:

- #APT and #ATEMPT: de-escalating studies update
- #DestinyBreast 02, 03, and 04: TDxD in mBC updates

https://twitter.com/somecme/status/1604974908458549249?s=46&t=I28CdbeOrNmWP-sYMuaXgA

#bcsm #SABCSUpdate 
@OncoAlert@twitter.com @SoMeCME@twitter.com @SABCSSanAntonio@twitter.com

🐦🔗: https://twitter.com/OncBrothers/status/1604975479685251074

#ATEMPT also looked at "right sizing" treatment w/ T-DM1 for small #HER2 #bcsm w/ similar fantastic outcomes.

📣ATEMPT2.0 will examine 6 months of T-DM1 as 1 yr was actually a bit harder to tolerate than we expected

#SABCS22 @OncoAlert@twitter.com

@PTarantinoMD@twitter.com @stolaney1@twitter.com